dc.contributor.author |
Constantinou-Kokotou, V |
en |
dc.contributor.author |
Karikas, G |
en |
dc.contributor.author |
Kokotos, G |
en |
dc.date.accessioned |
2014-06-06T06:44:46Z |
|
dc.date.available |
2014-06-06T06:44:46Z |
|
dc.date.issued |
2001 |
en |
dc.identifier.issn |
0960894X |
en |
dc.identifier.uri |
http://dx.doi.org/10.1016/S0960-894X(01)00115-9 |
en |
dc.identifier.uri |
http://62.217.125.90/xmlui/handle/123456789/2054 |
|
dc.subject.other |
2 deoxystreptamine |
en |
dc.subject.other |
aminoglycoside antibiotic agent |
en |
dc.subject.other |
DNA |
en |
dc.subject.other |
framycetin |
en |
dc.subject.other |
gentamicin |
en |
dc.subject.other |
kanamycin A |
en |
dc.subject.other |
neamine |
en |
dc.subject.other |
netilmicin |
en |
dc.subject.other |
RNA |
en |
dc.subject.other |
streptomycin |
en |
dc.subject.other |
article |
en |
dc.subject.other |
drug DNA binding |
en |
dc.subject.other |
gel permeation chromatography |
en |
dc.subject.other |
high performance liquid chromatography |
en |
dc.subject.other |
RNA binding |
en |
dc.subject.other |
Anti-Bacterial Agents |
en |
dc.subject.other |
Binding Sites |
en |
dc.subject.other |
Chromatography, High Pressure Liquid |
en |
dc.subject.other |
DNA |
en |
dc.subject.other |
Framycetin |
en |
dc.subject.other |
Kanamycin |
en |
dc.subject.other |
Neomycin |
en |
dc.subject.other |
Netilmicin |
en |
dc.subject.other |
RNA, Transfer |
en |
dc.title |
Study of aminoglycoside-nucleic acid interactions by an HPLC method |
en |
heal.type |
journalArticle |
en |
heal.identifier.primary |
10.1016/S0960-894X(01)00115-9 |
en |
heal.publicationDate |
2001 |
en |
heal.abstract |
The interactions of a number of aminoglycoside antibiotics with tRNA and DNA were studied by an HPLC method, based on tRNA and DNA peak size exclusion. Among the compounds studied (deoxystreptamine, neamine, neomycin B, kanamycin A, gentamicin A, netilmicin, streptomycin, and the synthetic neamine analogue BKN3), neomycin B and the synthetic analogue of neamine were proved to be the most potent binders. © 2001 Elsevier Science Ltd. |
en |
heal.journalName |
Bioorganic and Medicinal Chemistry Letters |
en |
dc.identifier.issue |
8 |
en |
dc.identifier.volume |
11 |
en |
dc.identifier.doi |
10.1016/S0960-894X(01)00115-9 |
en |
dc.identifier.spage |
1015 |
en |
dc.identifier.epage |
1018 |
en |